Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-22

Clinical Trial Update: Capsaicin for Post-stroke Dysphagia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating capsaicin for post-stroke dysphagia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capsaicin (capsaicin)

Snippet

Sponsor: Georg Kägi, MD | Conditions: Dysphagia, Late Effect of Stroke | Phase 2 | Status: UNKNOWN